Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

FASEB bioAdvances

Showing results (161-170 of 483) with videos related to

Pageof 49
Sort By:
FASEB Bioadvances|March 4, 2020
Cyclosporine A inhibits MRTF-SRF signaling through Na<sup>+</sup>/K<sup>+</sup> ATPase inhibition and actin remodelingBastien Burat, Quentin Faucher, Petra Čechová, et al.
FASEB Bioadvances|March 4, 2020
Aspirin ameliorates the long-term adverse effects of doxorubicin through suppression of cellular senescenceMingxiao Feng, Joohwee Kim, Kevin Field, et al.
FASEB Bioadvances|March 4, 2020
Ultrastructure of primary pacemaking cells in rabbit sino-atrial node cells indicates limited sarcoplasmic reticulum contentRamesh Iyer, Oliver Monfredi, Manuela Lavorato, et al.
FASEB Bioadvances|March 4, 2020
Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133<sup>+</sup> cells in clear cell renal carcinomaJohn R Bradley, Jun Wang, Simon Pacey, et al.
FASEB Bioadvances|March 4, 2020
Chronic alcohol consumption exacerbates murine cytomegalovirus infection via impairing nonspecific and specific NK activation in miceAlex Little, Yuanfei Li, Faya Zhang, et al.
FASEB Bioadvances|March 4, 2020
AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccineAkiko Tenma, Hironori Nakagami, Hideki Tomioka, et al.
FASEB Bioadvances|March 4, 2020
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activityEmi Hifumi, Hiroaki Taguchi, Eiichi Toorisaka, et al.
FASEB Bioadvances|March 4, 2020
Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptidesKadri Künnapuu, Kadi-Liis Veiman, Ly Porosk, et al.
FASEB Bioadvances|March 4, 2020
Calpain-mediated cleavage of p53 in human cytomegalovirus-infected lung fibroblastsZhenping Chen, Paul J Boor, Celeste C Finnerty, et al.
FASEB Bioadvances|March 4, 2020
A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strainsVipul Panchal, Nidhi Jatana, Anchal Malik, et al.
Pageof 49

Showing results (161-170 of 483) with videos related to

Sort By:
Pageof 49
FASEB Bioadvances|March 4, 2020
Cyclosporine A inhibits MRTF-SRF signaling through Na<sup>+</sup>/K<sup>+</sup> ATPase inhibition and actin remodelingBastien Burat, Quentin Faucher, Petra Čechová, et al.
FASEB Bioadvances|March 4, 2020
Aspirin ameliorates the long-term adverse effects of doxorubicin through suppression of cellular senescenceMingxiao Feng, Joohwee Kim, Kevin Field, et al.
FASEB Bioadvances|March 4, 2020
Ultrastructure of primary pacemaking cells in rabbit sino-atrial node cells indicates limited sarcoplasmic reticulum contentRamesh Iyer, Oliver Monfredi, Manuela Lavorato, et al.
FASEB Bioadvances|March 4, 2020
Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133<sup>+</sup> cells in clear cell renal carcinomaJohn R Bradley, Jun Wang, Simon Pacey, et al.
FASEB Bioadvances|March 4, 2020
Chronic alcohol consumption exacerbates murine cytomegalovirus infection via impairing nonspecific and specific NK activation in miceAlex Little, Yuanfei Li, Faya Zhang, et al.
FASEB Bioadvances|March 4, 2020
AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccineAkiko Tenma, Hironori Nakagami, Hideki Tomioka, et al.
FASEB Bioadvances|March 4, 2020
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activityEmi Hifumi, Hiroaki Taguchi, Eiichi Toorisaka, et al.
FASEB Bioadvances|March 4, 2020
Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptidesKadri Künnapuu, Kadi-Liis Veiman, Ly Porosk, et al.
FASEB Bioadvances|March 4, 2020
Calpain-mediated cleavage of p53 in human cytomegalovirus-infected lung fibroblastsZhenping Chen, Paul J Boor, Celeste C Finnerty, et al.
FASEB Bioadvances|March 4, 2020
A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strainsVipul Panchal, Nidhi Jatana, Anchal Malik, et al.
Pageof 49